About Alzamend Neuro (ALZN)
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic ... Read more
- USD3.12
- USD3.30
- USD3.10
- USD135.54
- -2.50%
- --
- 653.00
- 3.13M
- 3M
- 2.75
- -91.50%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
